Concepedia

Rodrigo Arcoverde Cerveira

RA

6

Publications

225

Citations

6

H-Index

2022

Active since

Affiliations

Karolinska Institutet(Current)

Karolinska University Hospital

National Institute of Allergy and Infectious Diseases

National Institutes of Health

CureVac (Germany)

Rodrigo Arcoverde Cerveira is an author at Karolinska Institutet specializing in virology, vaccination, and immunotherapy.

ORCID

Top concepts

Publications per year

2022–2024

6

Publications

6

Multivalent antigen display on nanoparticle immunogens increases B cell clonotype diversity and neutralization breadth to pneumoviruses

Sebastian Ols, Klara Lenart, Rodrigo Arcoverde Cerveira et al. · Immunity · 2023 · 64 citations · Full text

, , +15

Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses

Fredrika Hellgren, Alberto Cagigi, Rodrigo Arcoverde Cerveira et al. · Nature Communications · 2023 · 46 citations · Full text

, , +15

A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses

Klara Lenart, Fredrika Hellgren, Sebastian Ols et al. · Molecular Therapy — Methods & Clinical Development · 2022 · 43 citations · Full text

Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19

Meng Yu, Afandi Charles, Alberto Cagigi et al. · Nature Communications · 2023 · 27 citations · Full text

Three immunizations with Novavax’s protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2

Klara Lenart, Rodrigo Arcoverde Cerveira, Fredrika Hellgren et al. · npj Vaccines · 2024 · 25 citations · Full text

Rows per page

1–5 of 6